Literature DB >> 16618581

A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.

Bulent Aydogan1, Arno J Mundt, Brett D Smith, Loren K Mell, Steve Wang, Harold Sutton, John C Roeske.   

Abstract

PURPOSE: To evaluate the role of intensity-modulated radiation treatment (IMRT) as an alternative to high-dose-rate (HDR) brachytherapy in the treatment of the vagina in postoperative early endometrial cancer patients after surgery. METHODS AND MATERIALS: Planning computed tomography (CT) scans of 10 patients previously treated with HDR were used in this study. In all cases, a dose of 700 cGy/fraction was prescribed at a distance of 0.5 cm from the cylinder surface. The same CT scans were then used in IMRT planning. In this paradigm, the vaginal cylinder represents a component of a hypothetical immobilization system that would be indexed to the linac treatment table.
RESULTS: Our study showed that IMRT provided relatively lower rectal doses than HDR when treatment was prescribed at a distance of 0.5 cm away from the cylinder surface. Maximum rectal doses were lower with IMRT compared with HDR (average: 89.0% vs. 142.6%, respectively, p < 0.05). Moreover, the mean rectal dose was lower in IMRT plans compared with HDR plans with treatment prescribed either to the surface (average: 14.8% vs. 21.4%, respectively, p < 0.05) or to 0.5 cm (average: 19.6% vs. 33.5%, respectively, p < 0.05). IMRT plans had planning target volume (PTV) coverage comparable with HDR (average PTV minimum for treatment prescribed to 0.5 cm: 93.9% vs. 92.1%, p = 0.71, respectively) with less inhomogeneity (average PTV maximum: 110.8% vs. 381.6%, p < 0.05).
CONCLUSION: Our dosimetric analysis suggests that when used in conjunction with a suitable immobilization system, IMRT may provide an alternative to HDR brachytherapy in women with early endometrial cancer after hysterectomy. However, more studies are needed to evaluate the clinical merit of the IMRT in these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16618581     DOI: 10.1016/j.ijrobp.2005.12.049

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Current opinion in cervix carcinoma.

Authors:  Silvia Rodríguez Villalba; Carmen Díaz-Caneja Planell; José Manuel Cervera Grau
Journal:  Clin Transl Oncol       Date:  2011-06       Impact factor: 3.405

2.  High dose three-dimensional conformal boost using the real-time tumor tracking radiotherapy system in cervical cancer patients unable to receive intracavitary brachytherapy.

Authors:  Hee Chul Park; Shinichi Shimizu; Akio Yonesaka; Kazuhiko Tsuchiya; Yasuhiko Ebina; Hiroshi Taguchi; Norio Katoh; Rumiko Kinoshita; Masayori Ishikawa; Noriaki Sakuragi; Hiroki Shirato
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

3.  Dosimetric comparison of high dose rate brachytherapy and intensity-modulated radiation therapy for cervical carcinoma.

Authors:  B Shwetha; M Ravikumar; Siddanna R Palled; Sanjay S Supe; S Sathiyan
Journal:  J Med Phys       Date:  2011-04

4.  Radiobiological evaluation of the influence of dwell time modulation restriction in HIPO optimized HDR prostate brachytherapy implants.

Authors:  Panayiotis Mavroidis; Zaira Katsilieri; Vasiliki Kefala; Natasa Milickovic; Nikos Papanikolaou; Andreas Karabis; Nikolaos Zamboglou; Dimos Baltas
Journal:  J Contemp Brachytherapy       Date:  2010-10-13

Review 5.  Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?

Authors:  Sebastià Sabater; Ignacio Andres; Veronica Lopez-Honrubia; Roberto Berenguer; Marimar Sevillano; Esther Jimenez-Jimenez; Angeles Rovirosa; Meritxell Arenas
Journal:  Cancer Manag Res       Date:  2017-08-09       Impact factor: 3.989

6.  Retrospective feasibility study of simultaneous integrated boost in cervical cancer using Tomotherapy: the impact of organ motion and tumor regression.

Authors:  Fernanda G Herrera; Sharon Callaway; Ela Delikgoz-Soykut; Mehtap Coskun; Laetitia Porta; Jean-Yves Meuwly; Joao Soares-Rodrigues; Leonie Heym; Raphael Moeckli; Mahmut Ozsahin
Journal:  Radiat Oncol       Date:  2013-01-03       Impact factor: 3.481

7.  Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.

Authors:  Xianliang Wang; Jie Li; Pei Wang; Ke Yuan; Gang Yin; Bin Wan
Journal:  J Contemp Brachytherapy       Date:  2016-04-14

8.  Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.

Authors:  Gang Yin; Pei Wang; Jinyi Lang; Yin Tian; Yangkun Luo; Zixuan Fan; Kin Yip Tam
Journal:  J Contemp Brachytherapy       Date:  2016-06-14

9.  Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer.

Authors:  Piernicola Pedicini; Lidia Strigari; Rocchina Caivano; Alba Fiorentino; Giorgia Califano; Antonio Nappi; Giuseppina Improta; Giovanni Storto; Mariella Cozzolino; Costanza Chiumento; Vincenzo Fusco; Andrea Vavassori; Marcello Benassi; Roberto Orecchia; Marco Salvatore
Journal:  J Appl Clin Med Phys       Date:  2013-03-04       Impact factor: 2.102

Review 10.  The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry.

Authors:  Tibor Major; Georgina Fröhlich; Péter Ágoston; Csaba Polgár; Zoltán Takácsi-Nagy
Journal:  Strahlenther Onkol       Date:  2021-11-01       Impact factor: 3.621

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.